For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
2
views
0
references
 Top references
cited by
19
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      0
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: not found

      Guidance of sentinel lymph node biopsy decisions in patients with T1-T2 melanoma using gene expression profiling.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Can gene expression profiling be used to identify patients with T1-T2 melanoma at low risk for sentinel lymph node (SLN) positivity?

          Related collections

          Author and article information

          Journal
          Journal ID (iso-abbrev): Future Oncol
          Title: Future oncology (London, England)
          Publisher: Future Medicine Ltd
          ISSN (Electronic): 1744-8301
          ISSN (Print): 1479-6694
          Publication date (Electronic): Apr 2019
          Volume: 15
          Issue: 11
          Affiliations
          [1 ] Division of Surgical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.
          [2 ] Department of Surgery, St Louis University, St Louis, MO 63110, USA.
          [3 ] Department of Plastic Surgery, Cleveland Clinic Lerner Research Institute, Cleveland, OH 44915, USA.
          [4 ] Larry D Dillon Surgical Oncology & General Surgery, Colorado Springs, CO 80907, USA.
          [5 ] Castle Biosciences, Inc., Friendswood, TX 77546, USA.
          [6 ] Division of Surgical Oncology, Department of Surgery, The University of Tennessee Health Science Center, Memphis, TN 38163, USA.
          [7 ] Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago IL 60611, USA.
          [8 ] Skin Cancer Institute, Northwestern University, Lurie Comprehensive Cancer Center, Chicago, IL 60611, USA.
          [9 ] Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago IL 60611, USA.
          [10 ] Department of Dermatology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.
          [11 ] Department of Surgical Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
          [12 ] Department of Surgery, Thomas Jefferson University Hospital, Philadelphia, PA 19017, USA.
          Article
          DOI: 10.2217/fon-2018-0912
          PubMed ID: 30691297
          SO-VID: 109a7f78-72e8-4135-b905-613a202e42dd
          History

          Keywords: melanoma,prognosis,biomarker,sentinel lymph node biopsy,gene expression profiling
          Data availability:
          Keywords: melanoma, prognosis, biomarker, sentinel lymph node biopsy, gene expression profiling

          Comments

          Comment on this article